Prescient Therapeutics (PTX) News Today → Bitcoin Rockets To Record High But Buy THIS Instead (From Paradigm Press) (Ad) Free PTX Stock Alerts Add Compare Share Share HeadlinesStock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinePrescient Management Expands Portfolio with Additional PMXINC Securities Listingmsn.com - April 18 at 11:58 AMPrescient Management Expands PIPETF Securities in the Marketmsn.com - April 6 at 8:55 AMPrescient ETF Expands Offering with Additional Securities Listingmsn.com - April 4 at 10:27 AMPrescient ETF Expands with New Listings in Global Property Portfoliomsn.com - March 26 at 7:53 AMPrescient ETF Expands with New Securities Listingmsn.com - March 15 at 10:22 AMWe're Hopeful That Prescient Therapeutics (ASX:PTX) Will Use Its Cash Wiselyfinance.yahoo.com - March 6 at 4:55 PMPrescient Therapeutics Limitedafr.com - February 1 at 12:57 PMPrescient Therapeutics’ PTX-100 Phase 1b study shows excellent safety and promising efficacy in T-cell lymphoma patientsau.investing.com - December 10 at 8:33 PMMoneyTalks: Prescient set for ‘big pay day’; Aerometrex to grab ‘blue ocean’ AI opportunitymsn.com - November 20 at 10:06 AMPrescient Therapeutics nearing a potential payday with PTX-100: Pitt Street Researchproactiveinvestors.com.au - November 16 at 9:21 AMPrescient Therapeutics to participate in prestigious conference; abstract online nowau.investing.com - November 6 at 12:12 AMCancer fighter Prescient navigates challenging conditions for biotech, reports strong Q1 FY24msn.com - October 31 at 9:01 PMPrescient prepares to unveil Phase 1b cancer trial findings at world’s largest haematology conferencemsn.com - October 17 at 10:46 PMPrescient Therapeutics to present clinical data at prestigious US conferenceproactiveinvestors.com.au - October 16 at 9:43 PMASX cancer stocks guide: Here’s everything you need to knowmsn.com - September 19 at 4:01 PM‘Above and beyond approved therapies’: How Prescient Therapeutics is at the forefront of cancer fightingmsn.com - August 30 at 8:14 AMPrescient Therapeutics showcases cell therapy data at prestigious ISCT conferencefinance.yahoo.com - June 16 at 2:14 PMPrescient Therapeutics to present CellPryme and OmniCAR data to International Society of Cell and Gene Therapyproactiveinvestors.com.au - May 15 at 10:40 PMPrescient Therapeutics bolsters board with appointment of experienced US-based pharma executiveproactiveinvestors.com.au - May 15 at 2:38 AMPrescient Therapeutics (ASX:PTX) Is In A Good Position To Deliver On Growth Plansfinance.yahoo.com - April 20 at 9:16 PMPrescient Therapeutics' PTX-100 T Cell Lymphoma Phase 1b trial continues to show promising resultsproactiveinvestors.com.au - March 16 at 6:48 AMASX Health Stocks: High fives as Telix gets expanded FDA approval, Prescient’s PTX-100 returns good resultsmsn.com - March 15 at 10:38 PMPrescient Therapeutics thrilled with additional Orphan Drug Designation status for PTX-100proactiveinvestors.com.au - March 9 at 2:03 AMGuess which ASX biotech stock just rocketed 29% on big FDA newsmsn.com - March 8 at 9:03 PMPrescient Therapeutics granted US FDA additional Orphan Drug Designation for PTX-100; shares upproactiveinvestors.com - March 8 at 9:03 PMHere's Why Shareholders Will Not Be Complaining About Prescient Therapeutics Limited's (ASX:PTX) CEO Pay Packetfinance.yahoo.com - November 22 at 7:51 PMHere's Why We're Not Too Worried About Prescient Therapeutics' (ASX:PTX) Cash Burn Situationfinance.yahoo.com - November 12 at 12:09 AMPrescient Therapeutics provides PTX-100 trial update, readies for investor briefingproactiveinvestors.com.au - November 1 at 10:57 PMPrescient Therapeutics PTX-100 continues to exhibit excellent safety profileproactiveinvestors.com.au - October 25 at 10:20 PMProactive news headlines including AuTECO Minerals, Provaris Energy, Moho Resources and Prescient Therapeuticsyahoo.com - October 11 at 4:12 AMPrescient Therapeutics A$2.5 million top-up placement brings raise total to A$11.3 millionproactiveinvestors.com.au - October 10 at 11:10 PMPrescient Therapeutics exceeds SPP target, delivers top-up placement to accommodate demandproactiveinvestors.com - October 7 at 1:55 AMPrescient Therapeutics hails collaboration with MD Anderson Cancer Center for blood cancer therapyproactiveinvestors.com.au - September 11 at 10:22 PMPrescient Therapeutics to collaborate with largest cancer centre in the US to develop blood cancer treatmentproactiveinvestors.com.au - September 7 at 12:17 AMPrescient Therapeutics announces share purchase plan to raise $8 millionproactiveinvestors.com.au - September 2 at 1:50 AMWhy is the Prescient share price diving 12% on Wednesday?fool.com.au - August 24 at 4:04 AMPrescient developing "the next generation of OmniCAR cells" with Thermo Fisher Scientificproactiveinvestors.com.au - August 18 at 2:16 AMPrescient Therapeutics set to create scalable cell therapy platform with Thermo Fisher Scientificproactiveinvestors.com.au - August 17 at 9:16 PMPrescient Therapeutics enters into OmniCAR cell production agreement with Q-Gen Cellproactiveinvestors.com.au - August 16 at 10:11 AMPrescient Therapeutics Limited (PTX.AX)finance.yahoo.com - August 13 at 9:41 PMChallenging the pace of change in healthcare: Prescient Therapeuticsproactiveinvestors.com.au - August 3 at 3:36 AMProactive news headlines including Legacy Minerals, Matador Mining, Carnavale Resources and Prescient Therapeuticsfinance.yahoo.com - July 15 at 1:53 AMPrescient Therapeutics’ PTX-100 for peripheral T-cell lymphoma treatment granted US orphan drug statusproactiveinvestors.com.au - July 14 at 8:52 PMProactive news headlines including Prescient Therapeutics, Meeka Gold, Wiluna Mining Corporation and Alligator Energyfinance.yahoo.com - July 6 at 5:37 AMPrescient Therapeutics granted key US patent for OmniCAR portfolio of therapiesproactiveinvestors.com.au - July 6 at 12:36 AMPrescient Therapeutics delivers new clinic-ready cell therapy technologyproactiveinvestors.com.au - June 8 at 9:15 PMPrescient Therapeutics is making game-changing cancer therapies for a global marketproactiveinvestors.com.au - April 5 at 12:43 AMRace Oncology pursuing a three-pillar strategy to treat cancer: RaaS Advisoryproactiveinvestors.com.au - March 16 at 12:06 AMDespite shrinking by AU$13m in the past week, Prescient Therapeutics (ASX:PTX) shareholders are still up 195% over 3 yearsfinance.yahoo.com - March 7 at 6:34 PMPrescient Therapeutics half-year update shows why it’s one of the most exciting cancer research companies on the ASXmsn.com - March 1 at 7:26 PM Get Prescient Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTX and its competitors with MarketBeat's FREE daily newsletter. Email Address AI “wealth window” is closing soon! (Ad)Today, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry. I put together this personal video [HERE]… PTX Media Mentions By Week PTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PTX News Sentiment▼0.760.53▲Average Medical News Sentiment PTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PTX Articles This Week▼10▲PTX Articles Average Week Get Prescient Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for PTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Algernon Pharmaceuticals News ALK-Abelló A/S News Alpha Tau Medical News Arno Therapeutics News Artelo Biosciences News Ascletis Pharma News Awakn Life Sciences News AXIM Biotechnologies News BerGenBio ASA News BriaCell Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (ASX:PTX) was last updated on 4/19/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe “Perfect Storm” for GoldGold Safe ExchangeBiden’s $374B Giveaway Into This SectorDTIForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressYour Money is Not SafeAmerican AlternativeHe Is Giving Away BitcoinCrypto Swap ProfitsThe #1 Crypto for 2024InvestorPlaceThe "Smart Money" Is Ready for May 1st Are You?Stansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Prescient Therapeutics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.